This online programme has been designed for medical and clinical oncologists, who wish to improve their skills. The programme will expose participants to a full spectrum of issues in clinical and medical oncology from basic science to advanced knowledge of systemic therapy as well as in the multidisciplinary treatment approach.
The programme focuses on frequent cancers such as breast, lung, gastro-intestinal and gynaecological cancers. Furthermore, practical training will be offered in the frame of clinical case presentations, prepared and presented by the participants and faculty for an interactive discussion.
• To update the knowledge on basic science of clinical and medical oncology
• To enhance the competence and practical performance in systemic therapy of malignancies
• To enhance the competence and practical performance in multidisciplinary cancer care
• To update knowledge and get additional skills in supportive as well as palliative care
• To prepare for the board exam in clinical/medical oncology
THE MASTERCLASS IS:
• Clinically oriented
• Breast cancer
• Gastro-intestinal tumours
• Gynaecological tumours
• Lung cancer
• Genito-urinary cancers
Please note that selected participants will be paired and asked to prepare a clinical case together with a colleague from a different Country/Hospital.
It is possible we may need to change the participants' case topic in order to keep a balance between all tumour types.
Ahmed H. Abdelaziz, Ain Shams University Hospitals, Clinical Oncology Dpt., Cairo, EG
Joerg Beyer, University Hospital of Bern, Oncology and Medicine Dept., Bern, CH
Felipe A. Calvo Manuel, Clinica Universidad de Navarra, Dept. of Radiation Oncology, Madrid, ES
Fatima Cardoso, Champalimaud Clinical Center, Breast Unit, Lisbon, PT
Maria-João Cardoso, Champalimaud Foundation, Breast Unit, Lisbon, PT
Anastasia Constantinidou, Bank of Cyprus Oncology Centre and Medical School University of Cyprus, Dept. of Oncology, Nicosia, CY
Giuseppe Curigliano, European Institute of Oncology / University of Milan, New Drugs for Innovative Therapies Division, Milano, IT
Sara De Dosso, Oncology Institute of Southern Switzerland (IOSI), Medical Oncology Dpt., Bellinzona, CH
Rodrigo Dienstmann, Vall d’Hebron Institute of Oncology, Molecular Therapeutic Research Unit, Barcelona, ES
Andreas Dietz, University Hospital Leipzig, ENT Dpt., Leipzig, DE
Alexandru Eniu, Riviera-Chablais Hospital, Interdisciplinary Oncology Service, Rennaz, CH
Enriqueta Felip, Vall d'Hebron University Hospital, Dept. of Oncology, Barcelona, ES
Karim Fizazi, Gustave Roussy Institute, Cancer Medicine Dept., Villejuif, FR
Martin Früh, St. Gallen Cantonal Hospital, Dept. of Internal Medicine, St. Gallen, CH
Marina Garassino, National Cancer Institute - IRCCS Foundation, Medical Oncology Dept., Milano, IT
Fady B. Geara, American University of Beirut Medical Center, Dept. of Radiation Oncology, Riad El Solh, Beirut, LB
Robert Glynne-Jones, Mount Vernon Centre for Cancer Treatment, Radiotherapy Department, London, UK
Antonio Gonzalez Martin, Clínica Universidad de Navarra, Oncology Department, Madrid, ES
Federica Grosso, Azienda Ospedaliera Nazionale SS. Antonio e Biagio e C. Arrigo, ., Alessandria, IT
Izidor Kern, University Clinic Golnik, Dept. of Pathology, Golnik, SI
Angela Lamarca, The Christie NHS Foundation Trust, Medical Oncology Dept, Manchester, UK
Nicolas Mottet, University Jean Monnet, Dept. of Urology, Saint Etienne Cedex 2, FR
Olivia Pagani, Riviera-Chablais Hospital, Interdisciplinary Oncology Service, Rennaz, CH
Demetris Papamichael, Bank of Cyprus Oncology Centre, Medical Oncology Dpt., Nicosia, CY
Nicholas Pavlidis, University Hospital of Ioannina, Medical Oncology Dpt., Ioannina, GR
Graeme John Poston, Aintree University Hospital, Dept. of Surgery, Liverpool, UK
Giancarlo Pruneri, National Cancer Institute, IRCCS Foundation, Pathology Dpt., Milano, IT
Amanda Psyrri, Attikon University Hospital, Medical Oncology Dept., Chaidari, GR
Isabelle Ray-Coquard, Léon Bérard Center, Dept. of Medical Oncology, Lyon, FR
Christian Rolfo, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, Center for Thoracic Oncology, New York, US
Laura Rubbia-Brandt, Hôpitaux Universitaires Genève, Pathology Dept., Geneve, CH
Isabelle Schmitt-Opitz, University of Zurich Hospital, Dept. of Thoracic Surgery, Zurich, CH
Cristiana Sessa, Istituto Oncologico della Svizzera Italiana, Gynaecology Dpt., Bellinzona, CH
Thomas Seufferlein, Ulm University Hospital, Dept. of Internal Medicine I, Ulm, DE
Arndt Vogel, Medizine Hochschule Hannover, Gastrointestinal Oncology Dpt., Hannover, DE
Ursula Vogl, Cantonal Hospital of Southern Switzerland (EOC), Genitourinary Dept., Bellizona, CH
Ignacio Zapardiel, La Paz University Hospital, Gynecologic Oncology Unit, Madrid, ES
The Masterclass will be held in English and translation will not be provided.
Participants will be issued a certificate of attendance (minimum attendance: 75% of the entire course). An online evaluation questionnaire and learning assessment test will need to be completed in order to get the certificate that will be issued by email.
Application for CME recognition has been submitted to the Accreditation Council of Oncology in Europe (ACOE) and 22 CME credits have been granted to this event. The American Medical Association (AMA) and the Accreditation Council for Continuous Medical Education (ACCME) designate this type of educational activity for a maximum of 1 AMA PRA category 1 credits per hour of activity.
ESCO - The ESO College
Being selected to take part in an ESO Masterclass is one of the ESO activities that gives participants eligibility to enrol in ESCO - the College of the European School of Oncology.
A Masterclass also enables ESCO students to earn ESCO credits and therefore access more ESCO benefits.
Full and active participation in the Masterclass earns participants 30 ESCO credits.
Visit www.ESCO.org for more information on how to join ESCO.
Use the hashtag #ESOexperience and follow us on Facebook, Twitter and Instagram: @esoncology
Should you have any queries, please do not hesitate to contact the event organisers:
Corinne Hall - Faculty and Programme - email@example.com
Mariachiara Deleo - Applications and Participants - firstname.lastname@example.org
Francesca Marangoni - Online Programme and IT Settings - email@example.com
PARTICIPANT’S PROFILE OF THE MASTERCLASS CANDIDATE
- Age between 30 and 40 years
- 2-3 years’ experience in medical oncology
- Involvement in scientific activities and clinical trials
- Fluency in English
HOW TO APPLY
Interested oncologists should apply online (at the top of this page) providing:
- Letter describing motivation for attending;
- Supporting letter from head of department or mentor;
- CV with list publications (if the list of publications is not provided, it will be assumed that no articles have been published)
- Clinical case (see below)
- Professional experience form (see below)
Priority will be given to candidates practicing in the Arab and Southern European countries.
CLINICAL CASE PRESENTATION
You will have to present a clinical case at the Masterclass together with another participant. Your submitted abstract will be used to pair you with someone and together you will need to present one of the cases as a clinical grand round discussion. Please provide a straightforward case of your daily clinical practice - no uncommon or extremely rare cases. A maximum of 10 slides will be permitted containing:
- Diagnostic considerations
- Results, follow-up
- At least three questions proposed for discussion with the faculty
Before you start completing the online application form, please be sure you have all the requested files (CV, Motivation letter, Supporting letter, Professional experience template and Clinical Case template) ready to be uploaded to the system. Online applications will not be complete unless all the files are uploaded.